Familial thoracic aortic aneurysm and aortic dissection
MONDO:0019625A rare genetic vascular disease characterized by the familial occurrence of thoracic aortic aneurysm, dissection or dilatation affecting one or more aortic segments (aortic root, ascending aorta, arch or descending aorta) in the absence of any other associated disease. Depending on the size, location and progression rate of dilatation/dissection, patients may be asymptomatic or may present dyspnea, cough, jaw, neck, chest or back pain, head, neck or upper limb edema, difficulty swallowing, voice hoarseness, pale skin, faint pulse and/or numbness/tingling in limbs. Patients have increased risk of presenting life threatening aortic rupture.
Also known as: Erdheim disease, FTAAD, familial TAAD, familial aortic dissection, familial non-syndromic TAAD, familial thoracic aortic aneurysm and aortic dissection, nonsyndromic HTAD, nonsyndromic familial thoracic aortic aneurysm and dissection
12 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Aortic repair breakthrough: which blood flow restore method works best?
Disease control Not yet recruitingThis study looks at different methods to restore blood flow to the left subclavian artery when it must be covered during aortic repair. Covering this artery can raise the risk of stroke and arm problems. The trial compares surgical bypass with newer endovascular techniques to see…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
AI could personalize emergency treatment for deadly aortic tears
Disease control Not yet recruitingThis study tests whether using artificial intelligence to guide anti-inflammatory treatment can improve outcomes for people with acute aortic dissection, a life-threatening tear in the aorta. Researchers will enroll 300 adults undergoing emergency surgery and randomly assign them…
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a simple drug shield organs after aortic tear surgery?
Disease control Not yet recruitingThis study tests whether a drug called sivelestat sodium can reduce organ damage in people who have emergency surgery for a torn aorta (type A aortic dissection). About 236 patients will receive either the drug or a placebo for 3 days after surgery. The main goal is to see if the…
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:02 UTC